How Much Is Joint Replacement Reimbursement Being Cut in 2027?
CMS proposed the CY2027 Physician Fee Schedule on July 14, 2026. Here is what it actually does to hip and knee replacement pay, what the surgical community is saying about it, and the part a practice can still control.
- The numbers behind the 2027 proposal
- What the CY2027 rule actually proposes
- The 2027 impact at a glance
- Why the cut is bigger than the conversion factor
- The 25-year trendline on joint replacement pay
- What surgeons and operators are actually saying
- What a practice can still control
- How to take cost out of the back office
- Frequently asked questions
The Numbers Behind the 2027 Proposal
Figures below are from the CMS proposed rule and peer-reviewed reimbursement research, not from projections.
- The conversion factor is not the story. It moves about 1% to 2%. The proposed work RVU cuts on high-volume orthopedic codes are what produce the 8% to 9% number.
- CMS proposes orthopedic work RVUs that sit below even the AMA RUC recommendations, which had already reduced those values.
- This is a proposed rule, not final law. There is a comment period, and the final rule lands later in the year.
- Budget neutrality is the mechanism. Raising primary care payment inside a fixed pool means procedural specialties fund it. That is arithmetic, not a verdict on clinical value.
- Model the impact code by code. A blended specialty average will not tell you what happens to your specific case mix.
- The controllable variable is the cost and accuracy of getting paid: documentation gaps, missed charges, prior authorization, and denials.
What Does the CY2027 Fee Schedule Actually Propose?
Four provisions matter most if you do hip and knee replacement. The headline conversion factor is the least important of them.
CMS proposes a CY2027 qualifying APM conversion factor of $33.17, down $0.40 or 1.19% from $33.57, and a non-qualifying factor of $32.84, down $0.56 or 1.68% from $33.40. Part of that is mechanical: the one-year 2.50% conversion factor increase provided for CY2026 no longer applies in CY2027, so current law requires a 2.50% reduction against this year before anything else happens.
This is the real driver. CMS proposes to reduce work RVUs for several high-volume orthopedic procedures after identifying what it calls a site-of-service anomaly. The proposed values sit below even the AMA RUC recommendations, which had already reduced those values. Because the reduction hits the work RVU component rather than the conversion factor, it lands unevenly across codes and specialties.
CMS projects roughly 8% in facility settings and 5% in non-facility settings, for about 7% overall at the specialty level. Combined with the conversion factor decline, independent analysis estimates an average reduction on the order of 8% to 9% in PFS allowed charges, all else equal. Because that is a blended figure, joint replacement practices should model the impact code by code rather than applying the average.
For CY2027, CMS proposes to reduce payment when a separately identifiable office or outpatient evaluation and management visit is furnished by the same physician, or a physician in the same practice, on the same day as a 0, 10, or 90-day global procedure. The most expensive service would be paid at 100% and every other service that day at 50%. For practices that routinely see and treat in the same visit, this is a second, quieter cut sitting underneath the first.
The 2027 Orthopedic Impact on One Screen
Every figure below comes from the CMS proposed rule or peer-reviewed reimbursement research. Nothing here is modeled or projected by us.
Why Is the Cut Bigger Than the Conversion Factor?
Most coverage of any fee schedule leads with the conversion factor, because it is one number and it is easy to write about. It is also, this year, close to a rounding error next to what is happening to orthopedics specifically. A 1.19% to 1.68% conversion factor decline does not produce an 8% to 9% reduction. Revaluing the work RVUs on the codes you actually bill does.
Underneath that sits budget neutrality. The fee schedule operates as a fixed pool. If CMS increases payment for one set of services, the money has to be found inside the same pool, which means decreasing payment somewhere else. There is broad agreement, including among surgeons, that primary care has been undervalued for a long time and that correcting it is overdue. But because Medicare spends heavily on joint replacement, and because the population needing joint replacement keeps growing, procedural specialties are where a meaningful share of the offset gets found.
That is the part worth being precise about. The cut is not a determination that a hip replacement stopped being valuable. It is an arithmetic consequence of paying more for something else inside a pool that is not allowed to grow. Those are different claims, and conflating them is how a budgeting mechanism gets dressed up as a value judgment.
There is a second structural problem underneath the first. CMS has said it wants to migrate care into value-based arrangements, and most people agree that is directionally right. But there are currently no models, active or proposed, that allow direct surgeon participation in the way the rhetoric implies. It is difficult to push a specialty into models that do not yet exist for them.
Has Joint Replacement Pay Really Fallen This Far?
The 2027 proposal is not a single bad year. It sits on top of a 25-year trendline that is well documented in the peer-reviewed literature.
Yes, and the figure is not an advocacy number. A 2025 analysis published in The Journal of Arthroplasty examined Medicare reimbursement for primary and revision total hip and total knee arthroplasty from 2000 to 2024. After adjusting for inflation, reimbursement for primary hip and knee replacement decreased 56% over that period. Primary total knee arthroplasty fared worst, down 57% in inflation-adjusted dollars.
Set that against what the procedures do. Hip and knee replacement are among the most successful and cost-effective interventions in medicine. Roughly 90% to 95% of modern joint replacements are expected to last the patient’s lifetime, which is a durability profile very few interventions in any specialty can claim. A procedure whose real payment has been cut by more than half over a generation, while its clinical performance held, is a strange thing to describe as correctly valued.
None of that means the professional fee should be immune from review. It does mean the trendline is the context for the 2027 number, and any honest conversation about where the floor sits has to start there rather than at this year’s delta.
What Are Surgeons and Operators Saying About the Cut?
The proposal set off a candid debate among orthopedic surgeons, ASC operators, and practice leaders. We pulled the four arguments that actually move the discussion forward, and added where we land.
The surgeon who started the debate did the arithmetic most people had not gotten to yet. After the revaluation, he put the professional fee a surgeon takes home for a total hip or total knee at roughly $550, and reckoned joint replacement was down about 9% to 10%. That number is his own calculation rather than a CMS figure, and it deserves to be read that way. The question he attached to it is harder to wave off: nobody expects sympathy for orthopedic surgeons, so what is fair reimbursement for these procedures, and where is the floor?
What made the thread worth reading is that he conceded the other side of it. CMS wants to support primary care, and almost everyone agrees that is overdue. Because of budget neutrality, the money has to come from somewhere, and Medicare spends heavily on joint replacement. His objection was not that primary care should be paid less. It was that a budgeting mechanism is being narrated as a judgment about clinical value, and that surgeons are being pushed toward value-based models that do not yet exist for them.
This will create rapid consolidation and is unsustainable. I suspect it will accelerate surgeons opting out of Medicare, a true disservice for the beneficiaries.
The divergence between facility and physician reimbursement is becoming harder and harder to ignore. Increasing favor for those who own the platform, not just the procedure. Commercial bundles feel like the logical next frontier.
Some of these solutions are stupidly simple. If they want to rebalance towards primary care, then just pay more for it and commit to doing so over a longer period of time. There is no benefit to providers or patients reducing compensation for a surgeon to fund a program where two-thirds of the money will go to admins or vendors for “infrastructure.”
The uncomfortable question is where the floor actually is. If a procedure is highly effective, durable, and cost-effective, but the professional reimbursement keeps getting cut, at some point the system is no longer rewarding value. It is just exploiting the fact that surgeons will still show up.
We cannot answer the floor question, and we are suspicious of anyone in our category who claims they can. It is a policy argument, and it belongs to the surgeons and the societies making it during the comment period.
What we can offer is what we see from inside a lot of orthopedic back offices. Practices that treat an 8% cut as a pricing problem usually do nothing, because pricing is not theirs to change. The ones that treat it as a margin problem go looking for the points they are already giving away: the authorization that slipped past the surgery date, the technical denial nobody reworked inside the window, the charge that never got captured because a note sat unsigned. None of that offsets the cut. It only stops the cut from being compounded by leakage, which is a smaller claim than the ones usually made in this space, and it happens to be true.
The consolidation answer in this thread is a real one, and the facility-ownership answer is the sharpest economic read on the page. Both are decisions about ownership and structure. Neither helps you next quarter. Tightening what you already earn does.
What Can a Practice Actually Do About an 8% Cut?
You cannot vote on the conversion factor. You can decide how much of what you earned actually reaches the bank, and how much it costs you to get it there. When the rate drops, leakage stops being an annoyance and starts being the margin.
The 7% specialty figure is a blend. Your exposure depends on your case mix, your facility versus non-facility split, and how much of your volume sits in the revalued codes. Run your top codes against the proposed values before you plan next year’s budget around an average, and if nobody has audited your code selection lately, a coding audit tells you whether you are already leaving RVUs on the table.
A missing signature, an unlinked op note, or a thin medical-necessity narrative costs the same whether the rate is high or low. At a lower rate, the same gap eats a bigger share of what is left. Tighten the capture at the point of care rather than at appeal, which is what a virtual orthopedics assistant is for.
Elective joint replacement lives and dies on authorization. Every delayed auth pushes a case, and every pushed case moves revenue into a later period or loses it. Trained remote staff can own the queue, chase the payer, and keep the schedule intact. This is narrow enough to have its own playbook: joint replacement prior authorization and orthopedic prior authorization are not the same workflow as a generic prior authorization queue.
At a 56% real-terms decline, a written-off denial is not a rounding error. Root-cause the technical denials, rework them inside the window, and fix the upstream step that generated them so the same denial does not return next month. That is the whole job of revenue cycle management, and it is measurable.
Benefits checked late become patient balances that never collect. Verifying coverage, benefits, and patient responsibility before the date of service is the cheapest revenue protection in the building, and insurance verification is the one task where being early is worth more than being fast.
If the rate falls 8% and your administrative cost per claim holds, the margin absorbs all of it. Lowering the fully loaded cost of the back office is the one lever that moves in your favor while the fee schedule moves against you. That is the entire premise of outsourced medical support, and it is covered in the next section.
How Do You Take Cost Out of the Back Office Without Touching Care?
An 8% cut to the revenue line is only half the equation. The other half is what it costs you to collect what is left, and unlike the fee schedule, that number is negotiable.
Here is the part that gets skipped in most reimbursement conversations. When the rate falls and your administrative cost per claim stays flat, the margin absorbs the entire difference. The clinical work cannot be cheapened without hurting patients, and no orthopedic group should try. But almost none of the work that surrounds the case has to sit in your building at US salary.
Run the arithmetic on one back-office seat. A fully loaded in-house hire costs far more than the offer letter suggests once you add health benefits, payroll taxes, paid time off, per-user software licensing, equipment, and the turnover that hits administrative roles hardest. Remote coverage through outsourced medical support is a flat, predictable fee starting at $399 per week per assistant, $349 at five or more, and $299 at ten or more, with no commissions and no revenue share. At full-time coverage, $399 per week is roughly $8.87 an hour against a US market that generally runs $9.50 to $13.00 an hour for the same seat, before you count benefits at all.
The point is not that offshore is cheaper. Everyone knows that. The point is which specific functions can move without the patient ever noticing, and which cannot. These four move cleanly, and they happen to be exactly the four the 2027 proposal squeezes hardest.
An elective joint replacement that loses its authorization loses the whole case, not a percentage of it. A dedicated remote team working joint replacement prior authorization and orthopedic prior authorization owns the queue, chases the payer, and protects the surgical schedule. At an 8% lower rate, one saved case is worth more than it was last year.
Insurance verification done days early is a clean claim. Done late, it becomes a patient balance you will chase for months and probably write off. This is the cheapest possible place to protect revenue, and it is pure process work that does not need to happen in your office.
When CMS revalues the codes you live on, the gap between what you did and what you documented turns into money faster. A coding audit tells you whether you are already under-capturing before the new values even land, which is the difference between an 8% cut and an 8% cut plus whatever you were quietly leaving behind.
A denial written off because nobody had time is a full loss on a fee that already fell 56% in real terms since 2000. Revenue cycle management that root-causes technical denials and reworks them inside the appeal window is the highest-yield administrative work in an orthopedic practice, and it is almost never the work your best people have time for.
2027 Joint Replacement Reimbursement: Frequently Asked Questions
How much is Medicare cutting joint replacement pay in 2027?
CMS projects a 7% specialty-level reduction for orthopedic surgery in the CY2027 proposed rule, made up of roughly 8% in facility settings and 5% in non-facility settings. Once the conversion factor decline is layered on, independent analysis puts the average reduction on the order of 8% to 9% in allowed charges. Your actual result depends on your code mix, so model it code by code rather than assuming the headline number.
When was the CY2027 physician fee schedule released and when does it take effect?
CMS issued the CY2027 Physician Fee Schedule proposed rule on July 14, 2026. It proposes policies for Medicare Part B payments effective on or after January 1, 2027. It is a proposed rule, not final law, and it goes through a public comment period before a final rule is published later in the year.
Why is the cut bigger than the conversion factor change?
The conversion factor moves only a little. The proposed CY2027 qualifying APM conversion factor is $33.17, down 1.19%, and the non-qualifying factor is $32.84, down 1.68%. The larger hit to joint replacement comes from CMS proposing to cut the work RVUs on high-volume orthopedic procedures, citing what it calls a site-of-service anomaly. Those proposed values sit below even the AMA RUC recommendations, which had already reduced them.
Has joint replacement reimbursement really fallen 56% since 2000?
Yes, in inflation-adjusted terms. A 2025 analysis in The Journal of Arthroplasty found Medicare reimbursement for primary total hip and total knee arthroplasty decreased 56% between 2000 and 2024 after adjusting for inflation, with primary total knee arthroplasty down 57%. That is the long-run trend the 2027 proposal sits on top of.
What is budget neutrality and why does it drive these cuts?
Budget neutrality requires that increases in payment for some services be offset by decreases elsewhere within the fee schedule. When CMS raises payment for primary care, the money has to come from somewhere else in the same pool. Because Medicare spends heavily on joint replacement, procedural specialties absorb a large share of the offset. The mechanism is arithmetic, not a judgment about whether the procedure delivers value.
What can an orthopedic practice actually control when reimbursement is cut?
Payment policy sits outside any single practice’s control, but the cost of collecting the payment does not. When margins tighten, every preventable documentation gap, missed charge, delayed signature, denied prior authorization, and workflow breakdown has a larger financial impact. Strengthening revenue integrity and reducing administrative friction are the levers a practice still owns.
One Flat Weekly Rate. 45 Hours of Coverage.
No hourly meters, no setup fees, no long-term contracts. Your dedicated team member covers your desk 45 hours every week, and a trained backup steps in at no charge whenever they are out.
One dedicated remote specialist running prior authorization, verification, and denial rework for a single orthopedic practice
5+ remote specialists handling authorizations and denials across a multi-provider orthopedic group or several sites
10+ remote specialists running the revenue desk across a multi-location platform, MSO, or health system service line
45 hours of coverage for less than others charge for 40.
Standard US full-time year: 40 hrs x 52 weeks = 2,080 hours, the industry-standard basis for computing hourly pay (the federal government itself computes with a 2,087-hour divisor per the U.S. Office of Personnel Management; 2,080 is the standardized 40 x 52 convention). A Staffingly plan: 45 hrs x 52 weeks = 2,340 hours a year, that is 260 additional hours included in your flat rate. $399/week x 52 = $20,748 a year / 2,340 hours = $8.87 per hour. Estimated US market rates for healthcare virtual assistants run $9.50 to $13.00 per hour for 40 hours of coverage.
The Fee Schedule Is Not Negotiable. Your Back Office Is.
Every practice reading the CY2027 proposal is doing the same arithmetic: the rate is going down, the work is not, and the administrative cost of getting paid is sitting exactly where it was. Two of those three are outside your control.
That is the gap Staffingly fills. We provide HIPAA-trained remote staff who work inside your existing systems on prior authorization, eligibility and benefits verification, documentation follow-up, and denial rework. Our people work on company-controlled workstations, over secured connections, with software that stops copying or screenshots. We hold SOC 2 Type II and ISO 27001, our staff are HIPAA-trained, and we support 800-plus providers on flat-fee pricing starting at $399 per week, with no commissions and no revenue share.
We are not going to pretend this offsets a rate cut. It does not. What it does is make sure the cut is the only thing costing you money, instead of the cut plus a denial backlog plus an authorization queue nobody has time to work.
Read more: Staffingly reviews · Healthcare case studies · BPO success stories
This article is for general informational purposes and does not constitute legal, billing, or compliance advice. Proposed rule provisions can change before a final rule is published. Confirm payment impacts against the published rule and your own coding and compliance counsel before acting.
Written By
Dan Nandan has spent 25+ years in IT consulting and healthcare BPO, was among the first in the US to build an RPO/BPO delivery network, and has been featured in Computerworld. Staffingly supports 800-plus healthcare providers with remote prior authorization, billing, front-desk, and care coordination staff who operate under signed BAAs, on company-controlled workstations, inside whatever EHR and practice management system the group already runs.
Connect on LinkedInPut trained remote staff on your authorizations and denials in two weeks.
Start your 2-week free trial, or book a strategy call. Dan Nandan, CEO, joins most calls personally. Real conversation, real numbers for your practice.
or call directly: (800) 489-5877
Sources and note. Conversion factors, the projected specialty-level impact, and the same-day E/M provision are drawn from the CMS Calendar Year 2027 Medicare Physician Fee Schedule proposed rule, issued July 14, 2026. The 56% inflation-adjusted decline is from Palmer R, Elmenawi KA, Lieberman JR, Heckmann ND, Hannon CP, “Medicare Reimbursement for Primary and Revision Total Hip and Knee Arthroplasty: An Updated Analysis From 2000 to 2024,” J Arthroplasty. 2025 Sep;40(9S1):S100-S104.e1. The $550 per-case figure is a practicing surgeon’s own calculation as stated in the public discussion quoted above and is not independently verified here. Discussion comments are reproduced near-verbatim from a public professional thread with names withheld; views are the contributors’ own. Staffingly, Inc. is an independent BPO provider and is not affiliated with CMS. Proposed rule values may change before the final rule. SOC 2 Type II · ISO 27001 · HIPAA-Compliant · MGMA 2026 Corporate Member.